Product Description
Our reputable export firm offers Trabectidin Injections Yondelis to our foreign Clients since last many years from Surat, India.
- Generic Name: Trabectidin
- Brand Name: Yondelis Jannsen, Trabec Natco
- Strength: 1 mg
- Packing: Mon carton box along with patient leaflet
- Availability: In stock
- Dosage form: Injection
USE: Trabectidin injection is used to treat liposarcoma orleiomyosarcoma (a cancer that begins in smooth muscle tissue) that has spread to other parts of the body.
Tags: Trabectidin injection manufacturer, trabectidin injection exporter, trabectidin injection supplier, trabectidin injection drop shipper,yondelis injection exporter, trabec injection exporter, WHO GMP certified injectable manufacturer.
How to Prepare and Administer Yondelis InjectionYondelis Injection should be reconstituted using sterile water for injection. Gently swirl the vial to dissolve the powder completely within five minutes. Wear personal protective equipment during this process. After reconstitution, the solution is given via intravenous infusion, typically in a clinical or hospital setting by trained healthcare professionals.
Where and When to Use Yondelis InjectionThis medication is indicated for adult patients diagnosed with soft tissue sarcoma or relapsed ovarian cancer. Administration must be done in medical facilities under the supervision of qualified staff. Complete the reconstitution and infusion procedure promptly after preparation to maintain its potency and effectiveness.
Product Features and Storage GuidelinesYondelis is provided in a single-use, Type I glass vial, ensuring sterility and convenience for hospital use. The lyophilized powder is odorless and dissolves easily. Always store Yondelis Injection in a cool, dry place and use the product before its 24-month shelf life expires.
FAQ's of Yondelis Injection:
Q: How should Yondelis Injection be reconstituted and administered?
A: Dissolve the lyophilized powder in sterile water for injection by gentle swirling for about five minutes. Ensure all powder is fully dissolved, then administer the solution via intravenous infusion in a clinical or hospital setting using standard procedures and personal protective equipment.
Q: What clinical conditions is Yondelis Injection used to treat?
A: Yondelis Injection is primarily used for the treatment of soft tissue sarcoma and relapsed ovarian cancer in adult patients. It should only be used upon prescription and under specialist supervision.
Q: When should Yondelis Injection be administered?
A: Yondelis should be administered after proper reconstitution, as soon as possible, and only by trained healthcare professionals within a controlled medical environment. Dosage and timing are determined by your physician based on body surface area and treatment protocols.
Q: Where is Yondelis Injection intended to be used and by whom?
A: Yondelis Injection is intended for use in hospitals or clinical settings due to its complex reconstitution and administration requirements. Only registered medical practitioners or trained nursing staff should handle the product.
Q: What safety precautions should be followed during preparation and infusion?
A: Healthcare workers must wear appropriate personal protective equipment (PPE) while reconstituting and administering Yondelis Injection to prevent exposure. Follow all institutional guidelines for handling cytotoxic agents.
Q: What are the storage requirements for Yondelis Injection?
A: Keep Yondelis Injection in its original carton and store it in a cool, dry place. Ensure it is protected from excessive heat and moisture, and use it before the 24-month expiration date on the packaging.
Q: What are the benefits of using Yondelis Injection?
A: Yondelis Injection offers a highly purified, effective option for treating difficult cancers like soft tissue sarcoma and relapsed ovarian cancer. It is supplied as a single-use vial for sterility and safety, making it suitable for hospital and clinical administration.